JW, PhD

Pharmaceutical Facts Investors Should Know

As a researcher I can safely reply to DB, that the cost of drugs like the one mentioned for Gaucher's disease (a niche illness) must be passed on to consumers due to the great expense incurred by big pharma during clinical trials. I don't doubt that NIH and other taxpayer-funded R&D contribute greatly to the discovery process, but they don't typically have the financial resources to "prove" that a new compound is efficacious and safe enough to be used in the population at large.